These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

823 related articles for article (PubMed ID: 33744303)

  • 1. Retrospective serosurveillance for anti-SARS-CoV-2 immunoglobulin during a time of low prevalence: A cautionary tale.
    Bird PW; Holmes C; Fletcher O; Badhwar V; Toovey O; Tang JW
    J Infect; 2021 Jul; 83(1):119-145. PubMed ID: 33744303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.
    Mboumba Bouassa RS; Péré H; Tonen-Wolyec S; Longo JD; Moussa S; Mbopi-Keou FX; Mossoro-Kpinde CD; Grésenguet G; Veyer D; Bélec L
    J Med Virol; 2021 Apr; 93(4):2196-2203. PubMed ID: 33107601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low-prevalence setting.
    Skittrall JP; Wilson M; Smielewska AA; Parmar S; Fortune MD; Sparkes D; Curran MD; Zhang H; Jalal H
    Clin Microbiol Infect; 2021 Mar; 27(3):469.e9-469.e15. PubMed ID: 33068757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases.
    Kharlamova N; Dunn N; Bedri SK; Jerling S; Almgren M; Faustini F; Gunnarsson I; Rönnelid J; Pullerits R; Gjertsson I; Lundberg K; Månberg A; Pin E; Nilsson P; Hober S; Fink K; Fogdell-Hahn A
    Front Immunol; 2021; 12():666114. PubMed ID: 34012450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical performances of five SARS-CoV-2 whole-blood finger-stick IgG-IgM combined antibody rapid tests.
    Péré H; Mboumba Bouassa RS; Tonen-Wolyec S; Podglajen I; Veyer D; Bélec L
    J Virol Methods; 2021 Apr; 290():114067. PubMed ID: 33476707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-scale IgM and IgG SARS-CoV-2 serological screening among healthcare workers with a low infection prevalence based on nasopharyngeal swab tests in an Italian university hospital: Perspectives for public health.
    Vimercati L; Stefanizzi P; De Maria L; Caputi A; Cavone D; Quarato M; Gesualdo L; Lopalco PL; Migliore G; Sponselli S; Graziano G; Larocca AMV; Tafuri S
    Environ Res; 2021 Apr; 195():110793. PubMed ID: 33508260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating a SARS-CoV-2 screening strategy based on serological tests.
    Baccini M; Mattei A; Rocco E; Vannucci G; Mealli F
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):193-199. PubMed ID: 33412810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassay.
    Kittel M; Findeisen P; Muth MC; Thiaucourt M; Gerhards C; Neumaier M; Haselmann V
    Int J Infect Dis; 2021 Apr; 105():632-638. PubMed ID: 33578017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) universal screening in gravids during labor and delivery.
    Savirón-Cornudella R; Villalba A; Zapardiel J; Andeyro-Garcia M; Esteban LM; Pérez-López FR
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():400-404. PubMed ID: 33285496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies.
    Boukli N; Le Mene M; Schnuriger A; Cuervo NS; Laroche C; Morand-Joubert L; Gozlan J
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848041
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.
    Chiereghin A; Zagari RM; Galli S; Moroni A; Gabrielli L; Venturoli S; Bon I; Rossini G; Saracino IM; Pavoni M; Lafratta S; Deni A; Felici S; Borghi M; Guerra L; Raumer L; Lodi V; Viale P; Attard L; Lazzarotto T;
    Front Public Health; 2020; 8():620222. PubMed ID: 33681115
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluating 10 Commercially Available SARS-CoV-2 Rapid Serological Tests by Use of the STARD (Standards for Reporting of Diagnostic Accuracy Studies) Method.
    Dortet L; Ronat JB; Vauloup-Fellous C; Langendorf C; Mendels DA; Emeraud C; Oueslati S; Girlich D; Chauvin A; Afdjei A; Bernabeu S; Le Pape S; Kallala R; Rochard A; Verstuyft C; Fortineau N; Roque-Afonso AM; Naas T
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33239381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sars-Cov-2 Infection Screening Using Two Serological Testing Methods.
    Arinola OG; Edem VF; Rahamon SK; Yaqub SA; Fashina AO; Alonge TO
    Niger J Physiol Sci; 2020 Dec; 35(2):117-121. PubMed ID: 34009193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays.
    Merrill AE; Jackson JB; Ehlers A; Voss D; Krasowski MD
    J Appl Lab Med; 2020 Nov; 5(6):1351-1357. PubMed ID: 32717056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reliability of SARS-CoV-2 IgG antibody testing - a pilot study in asymptomatic health care workers in a Croatian university hospital.
    Lapić I; Rogić D; Šegulja D; Kralik Oguić S; Knežević J
    Croat Med J; 2020 Dec; 61(6):485-490. PubMed ID: 33410294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic.
    Pereckaitė L; Dambrauskienė A; Urbonienė D; Sadauskas S; Petrikonis K; Naudžiūnas A; Vitkauskienė A
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562085
    [No Abstract]   [Full Text] [Related]  

  • 17. Analytical and Clinical Analysis of Two Automated Anti-SARS-CoV-2 Immunoassays in Pre-Pandemic and Pandemic Patient Populations.
    Yang J; Pederson EC; Hamilton C; Neibauer T; Robyak K; McGhee P; Speicher T; Zhu Y
    J Appl Lab Med; 2021 Mar; 6(2):441-450. PubMed ID: 33152084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of over-diagnosis in serological testing. Implications for communications strategies.
    Biggeri A; Forni S; Braga M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):184-192. PubMed ID: 33412809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Light and Shadow of Rapid Serological Tests for SARS-CoV-2 Infection: Results from a Study in a Large Emergency Department.
    Loconsole D; Centrone F; Morcavallo C; Campanella S; Sallustio A; Quarto M; Procacci V; Chironna M
    Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32906596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side-by-Side Comparison of Three Fully Automated SARS-CoV-2 Antibody Assays with a Focus on Specificity.
    Perkmann T; Perkmann-Nagele N; Breyer MK; Breyer-Kohansal R; Burghuber OC; Hartl S; Aletaha D; Sieghart D; Quehenberger P; Marculescu R; Mucher P; Strassl R; Wagner OF; Binder CJ; Haslacher H
    Clin Chem; 2020 Nov; 66(11):1405-1413. PubMed ID: 32777031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.